These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 22692549)
1. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. Hedmer M; Wohlfart G J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549 [TBL] [Abstract][Full Text] [Related]
2. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760 [TBL] [Abstract][Full Text] [Related]
3. Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project. Sottani C; Grignani E; Oddone E; Dezza B; Negri S; Villani S; Cottica D Ann Work Expo Health; 2017 Oct; 61(8):994-1002. PubMed ID: 29028251 [TBL] [Abstract][Full Text] [Related]
4. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project. Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441 [TBL] [Abstract][Full Text] [Related]
5. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations. Connor TH; Zock MD; Snow AH J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784 [TBL] [Abstract][Full Text] [Related]
7. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Schierl R; Böhlandt A; Nowak D Ann Occup Hyg; 2009 Oct; 53(7):703-11. PubMed ID: 19620232 [TBL] [Abstract][Full Text] [Related]
8. Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital. Yoshida J; Koda S; Nishida S; Nakano H; Tei G; Kumagai S Ann Occup Hyg; 2013 Mar; 57(2):251-60. PubMed ID: 23002276 [TBL] [Abstract][Full Text] [Related]
9. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Hedmer M; Tinnerberg H; Axmon A; Jönsson BA Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576 [TBL] [Abstract][Full Text] [Related]
10. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
11. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Hon CY; Teschke K; Demers PA; Venners S Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Hedmer M; Jönsson BA; Nygren O J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047 [TBL] [Abstract][Full Text] [Related]
13. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
14. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study. Roland C; Caron N; Bussières JF J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754 [TBL] [Abstract][Full Text] [Related]
15. A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments. Dugheri S; Bonari A; Pompilio I; Boccalon P; Mucci N; Arcangeli G Arh Hig Rada Toksikol; 2018 Sep; 69(3):226-237. PubMed ID: 30285941 [TBL] [Abstract][Full Text] [Related]
16. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696 [TBL] [Abstract][Full Text] [Related]
17. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device. Siderov J; Kirsa S; McLauchlan R J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of gemcitabine, taxol, cyclophosphamide and ifosfamide in wipe samples by high-performance liquid chromatography/tandem mass spectrometry: protocol of validation and uncertainty of measurement. Sottani C; Turci R; Schierl R; Gaggeri R; Barbieri A; Violante FS; Minoia C Rapid Commun Mass Spectrom; 2007; 21(7):1289-96. PubMed ID: 17340557 [TBL] [Abstract][Full Text] [Related]
19. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. Hon CY; Teschke K; Chu W; Demers P; Venners S J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810 [TBL] [Abstract][Full Text] [Related]
20. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]